Profile
Daniel Wilson currently works at Dyne Therapeutics, Inc., as Senior Vice President & Head-Legal from 2020.
Mr. Wilson also formerly worked at Celgene Corp., as Senior Corporate Counsel from 2012 to 2020 and Sumitomo Pharma America, Inc., as Counsel-Intellectual Property.
Mr. Wilson received his graduate degree in 1994 from the University of Pennsylvania, undergraduate degree in 1992 from Swarthmore College, and graduate degree in 1998 from Boston University School of Law.
Daniel Wilson active positions
| Companies | Position | Start |
|---|---|---|
| DYNE THERAPEUTICS, INC. | General Counsel | 31/05/2020 |
Former positions of Daniel Wilson
| Companies | Position | End |
|---|---|---|
| CELGENE | General Counsel | 31/12/2019 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | - |
Training of Daniel Wilson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swarthmore College
Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
- Stock Market
- Insiders
- Daniel Wilson
















